Sign in

Research summary ·

Diagnostic utility of quantitative susceptibility mapping in Parkinson's disease and atypical parkinsonism: A systematic review and meta-analysis.

Written based on 1 research study on PubMed, searched on 3 Nov 2026.

What was studied

This review looked at a brain scan method called QSM. It is an MRI method that measures iron in tissue. The aim was to see if it can tell Parkinson's disease from related disorders. The related disorders were MSA and PSP. The authors searched several databases for studies in people and healthy controls. They pooled 12 studies. These had 626 people with Parkinson's disease, 160 with MSA and 176 with PSP. There were also 256 healthy controls.

What they found

The substantia nigra showed more iron signal in Parkinson's disease than in related disorders. MSA showed higher signal in the putamen. PSP showed the biggest rise in the red nucleus. The area under the curve was 0.83 for MSA and 0.89 for PSP. Signs of small-study effects were seen in the putamen MSA results.

What it means for patients

The authors conclude that QSM shows disorder-specific patterns of iron in these diseases. They say it may add value for telling them apart when used with clinical data.

Why it is not certain yet

The studies used different scan settings, scanner makers and field strengths. The authors say these differences may change the readings. They call for standard scan and processing methods. The studies were observational. Results for PSP varied a lot between studies.

Source

Diagnostic utility of quantitative susceptibility mapping in Parkinson's disease and atypical parkinsonism: A systematic review and meta-analysis.

PubMed · PMID 42035898

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Multiple system atrophy publications